The effect of branched-chain amino acid supplementation on cancer treatment.
Nutr Health
; 29(4): 621-635, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-36703299
ABSTRACT
Background:
Anticancer therapies are associated with significant adverse side effects and few treatments that alleviate symptoms exist. Branched-chain amino acids (BCAAs) have been investigated as an intervention for reducing anticancer therapy side effects, although a review of the literature results has yet to be published.Aim:
The current review summarizes evidence surrounding this topic and suggests both support and caution in using BCAAs as a treatment for patients receiving anticancer therapies.Methods:
In this review, two literature searches were completed. Google Scholar, PubMed, EBSCOhost, and Cochrane databases were searched using the terms "branched-chain amino acids and cancer" and "BCAA and cancer."Results:
Two bodies of evidence emerged One supporting beneficial effects and the other showing adverse outcomes of BCAA supplementation in patients with cancer. Evidence of benefit was a decrease in malnourishment and unintentional weight loss during and after chemotherapy. Potential harms included the idea cancer cells may utilize BCAAs as a source of energy for growth.Conclusions:
Supplementation of BCAAs in individuals with cancer should be implemented cautiously. Those who are severely malnourished due to anticancer therapy may benefit the most. BCAA supplementation may also be provided once cancer has been destroyed from the individual's body to aid with recovery.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Amino Acids, Branched-Chain
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Nutr Health
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos